For the Media
Dr. Jonathan Bricker is a member of Fred Hutch's Public Health Sciences Division. His research focuses on the development and testing of innovative interventions for health behavior change. With over $14 million in NIH research funding, he and his team are conducting randomized clinical trials of acceptance and commitment therapy interventions for smoking cessation.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.